Oxford University spin-out develops new test for heart disease
The CEO of a medtech spin-out from Oxford University has described how being paired with a group of experienced business mentors has helped his team commercialise a new way of diagnosing heart disease.
Founded by four Oxford cardiologists, Caristo Diagnostics has developed a new test that analyses routine heart scans for signs of inflammation in the coronary arteries, which supply blood to the heart. It’s known that inflammation in the coronary arteries is a key feature in the lead up to heart attacks.
You can read the write-up here.
American Heart Association Late-Breaking Science Presentation Reveals Majority of Adverse Cardiac Events Occur Among Patients Without Obstructive Coronary Artery Disease but Risks Are Detectable by Novel AI
Press Release Caristo’s AI Technology for Coronary Inflammation Measurement and Risk Assessment Can Transform Risk Stratification and Management of Patients…
British Heart Foundation Features Breakthrough Heart Attack Prevention Technology in Online News Programme for World Heart Day
Press Release British Heart Foundation Features Breakthrough Heart Attack Prevention Technology in Online News Programme for World Heart Day CaRi-Heart®…